Across TCGA pan-cancer cohorts, WBP1LP12 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated WBP1LP12 data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher WBP1LP12 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated WBP1LP12 expression acts as an unfavorable survival marker.
STAD are the cancer types where WBP1LP12 RNA most reproducibly stratifies survival.